 |
 |
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Animal Model:
|
Rodent Prenatal Immune Challenge: PolyI:C (delivery timing varies)
|
|
Preparation Type:
|
Developmental Preparations
|
|
DA-related behavior:
|
No change in total distance traveled in open field but
reduced center exploration; increased response to
amphetamine and MK-801 (emerges after puberty)--not rescued
by cross-fostering
|
|
Gating:
|
Disrupted PPI and changes in latent inhibition
(post-puberty); PPI deficit not rescued by cross-fostering
|
|
Cognitive behavior:
|
Reduced escape latency in Morris water maze; impairment n
novel object recognition memory and latent inhibition
(post-puberty); classical fear conditioning, active
avoidance and discrimination learning appear normal
|
|
Social behavior:
|
Reduced social interaction
|
|
Molecular/morphological signature:
|
Amphetamine-induced DA release increased; increased
hippocampal pyknotic cells; increased DA turnover and
reduced binding to D2 receptors in striatum; reduced reelin-
and parvalbumin- expressing neurons in PFC; reduced D1
receptors in PFC; increased TH expression in striatum;
reduced density of cerebellar Purkinje cells; delayed
myelination of hippocampus
|
|
Response to APD:
|
Deficits in latent inhibition and novel object recognition
memory are improved by clozapine but not haloperidol
|
|
|
 |
|
 |